Skip to main content
Top
Published in: Diabetologia 10/2015

01-10-2015 | Article

IL-7 receptor deletion ameliorates diet-induced obesity and insulin resistance in mice

Authors: Miyoung Lee, Su Jin Song, Myung-Sook Choi, Rina Yu, Taesun Park

Published in: Diabetologia | Issue 10/2015

Login to get access

Abstract

Aim/hypothesis

Obesity-induced inflammation plays an important role in the development of insulin resistance and type 2 diabetes. Recent studies have demonstrated that adiposity can be improved by ablating certain inflammatory signalling pathways. Although the IL-7 receptor (IL-7R) is mostly known as a key regulator of T lymphocyte development and homeostasis, its role in obesity and metabolic diseases is unknown. Because IL-7 is markedly increased in the serum of obese individuals and IL-7R (also known as IL7R) is overexpressed in white adipose tissue (WAT) in obesity, we studied the metabolic consequences of genetic Il-7r ablation in mice.

Methods

Age-matched Il-7r-deficient (Il-7r KO) and wild-type (WT) littermates were fed a standard chow or high-fat diet (HFD) for 14 weeks. Their serum metabolic variables were measured. The expression of genes and proteins related to insulin resistance and inflammation was evaluated in WAT.

Results

We demonstrated that Il-7r KO mice exhibited significantly reduced body weight gain and visceral adiposity compared with WT controls on both chow and HFD. The expression of signalling molecules involved in adipogenesis was reduced in the WAT of Il-7r KO mice. We also found that Il-7r KO mice had significantly enhanced glucose homeostasis and insulin sensitivity. Consistent with an improved metabolic phenotype, proinflammatory cytokine production and macrophage infiltration was attenuated in the WAT of Il-7r KO mice.

Conclusions/interpretation

The IL-7R plays an important role in the induction of HFD-induced adipogenesis and insulin resistance in mice.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fry TJ, Mackall CL (2005) The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J Immunol 174:6571–6576CrossRefPubMed Fry TJ, Mackall CL (2005) The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J Immunol 174:6571–6576CrossRefPubMed
2.
go back to reference Foxwell BM, Beadling C, Guschin D, Kerr I, Cantrell D (1995) Interleukin-7 can induce the activation of Jak 1, Jak 3 and STAT 5 proteins in murine T cells. Eur J Immunol 25:3041–3046CrossRefPubMed Foxwell BM, Beadling C, Guschin D, Kerr I, Cantrell D (1995) Interleukin-7 can induce the activation of Jak 1, Jak 3 and STAT 5 proteins in murine T cells. Eur J Immunol 25:3041–3046CrossRefPubMed
3.
go back to reference Pallard C, Stegmann AP, van Kleffens T, Smart F, Venkitaraman A, Spits H (1999) Distinct roles of the phosphatidylinositol 3-kinase and STAT5 pathways in IL-7-mediated development of human thymocyte precursors. Immunity 10:525–535CrossRefPubMed Pallard C, Stegmann AP, van Kleffens T, Smart F, Venkitaraman A, Spits H (1999) Distinct roles of the phosphatidylinositol 3-kinase and STAT5 pathways in IL-7-mediated development of human thymocyte precursors. Immunity 10:525–535CrossRefPubMed
4.
5.
go back to reference Mazzucchelli R, Durum SK (2007) Interleukin-7 receptor expression: intelligent design. Nat Rev Immunol 7:144–154CrossRefPubMed Mazzucchelli R, Durum SK (2007) Interleukin-7 receptor expression: intelligent design. Nat Rev Immunol 7:144–154CrossRefPubMed
6.
go back to reference Buckley RH (2004) Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol 22:625–655CrossRefPubMed Buckley RH (2004) Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol 22:625–655CrossRefPubMed
7.
go back to reference Puel A, Ziegler SF, Buckley RH, Leonard WJ (1998) Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet 20:394–397CrossRefPubMed Puel A, Ziegler SF, Buckley RH, Leonard WJ (1998) Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet 20:394–397CrossRefPubMed
9.
go back to reference Scherer PE (2006) Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55:1537–1545CrossRefPubMed Scherer PE (2006) Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55:1537–1545CrossRefPubMed
10.
go back to reference Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S (2007) Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 56:1010–1013CrossRefPubMed Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S (2007) Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 56:1010–1013CrossRefPubMed
11.
go back to reference Xu H, Barnes GT, Yang Q et al (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821–1830PubMedCentralCrossRefPubMed Xu H, Barnes GT, Yang Q et al (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821–1830PubMedCentralCrossRefPubMed
12.
go back to reference Olefsky JM, Glass CK (2010) Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 72:219–246CrossRefPubMed Olefsky JM, Glass CK (2010) Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 72:219–246CrossRefPubMed
13.
go back to reference Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87–91CrossRefPubMed Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87–91CrossRefPubMed
14.
go back to reference Paz K, Hemi R, LeRoith D et al (1997) A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem 272:29911–29918CrossRefPubMed Paz K, Hemi R, LeRoith D et al (1997) A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem 272:29911–29918CrossRefPubMed
15.
go back to reference Aguirre V, Uchida T, Yenush L, Davis R, White MF (2000) The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 275:9047–9054CrossRefPubMed Aguirre V, Uchida T, Yenush L, Davis R, White MF (2000) The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 275:9047–9054CrossRefPubMed
16.
go back to reference Serrano-Marco L, Rodriguez-Calvo R, El Kochairi I et al (2011) Activation of peroxisome proliferator-activated receptor-β/-δ(PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6 stimulated adipocytes. Diabetes 60:1990–1999PubMedCentralCrossRefPubMed Serrano-Marco L, Rodriguez-Calvo R, El Kochairi I et al (2011) Activation of peroxisome proliferator-activated receptor-β/-δ(PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6 stimulated adipocytes. Diabetes 60:1990–1999PubMedCentralCrossRefPubMed
17.
go back to reference Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE (2001) Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 9:414–417CrossRefPubMed Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE (2001) Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 9:414–417CrossRefPubMed
18.
go back to reference Alderson MR, Tough TW, Ziegler SF, Grabstein KH (1991) Interleukin 7 induces cytokine secretion and tumoricidal activity by human peripheral blood monocytes. J Exp Med 173:923–930CrossRefPubMed Alderson MR, Tough TW, Ziegler SF, Grabstein KH (1991) Interleukin 7 induces cytokine secretion and tumoricidal activity by human peripheral blood monocytes. J Exp Med 173:923–930CrossRefPubMed
20.
go back to reference Hartgring SA, Willis CR, Alcorn D et al (2010) Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators. Arthritis Rheum 62:2716–2725CrossRefPubMed Hartgring SA, Willis CR, Alcorn D et al (2010) Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators. Arthritis Rheum 62:2716–2725CrossRefPubMed
21.
go back to reference Hartgring SA, Willis CR, Bijlsma JW, Lafeber FP, van Roon JA (2012) Interleukin-7-aggravated joint inflammation and tissue destruction in collagen-induced arthritis is associated with T cell and B cell activation. Arthritis Res Ther 14:R137PubMedCentralCrossRefPubMed Hartgring SA, Willis CR, Bijlsma JW, Lafeber FP, van Roon JA (2012) Interleukin-7-aggravated joint inflammation and tissue destruction in collagen-induced arthritis is associated with T cell and B cell activation. Arthritis Res Ther 14:R137PubMedCentralCrossRefPubMed
22.
go back to reference Willis CR, Seamons A, Maxwell J et al (2012) Interleukin-7 receptor blockade suppresses adaptive and innate inflammatory responses in experimental colitis. J Inflamm (Lond) 9:39CrossRef Willis CR, Seamons A, Maxwell J et al (2012) Interleukin-7 receptor blockade suppresses adaptive and innate inflammatory responses in experimental colitis. J Inflamm (Lond) 9:39CrossRef
23.
go back to reference Ohana M, Okazaki K, Oshima C et al (2001) A critical role for IL-7R signaling in the development of Helicobacter felis-induced gastritis in mice. Gastroenterology 121:329–336CrossRefPubMed Ohana M, Okazaki K, Oshima C et al (2001) A critical role for IL-7R signaling in the development of Helicobacter felis-induced gastritis in mice. Gastroenterology 121:329–336CrossRefPubMed
24.
go back to reference Maury E, Ehala-Aleksejev K, Guiot Y, Detry R, Vandenhooft A, Brichard SM (2007) Adipokines oversecreted by omental adipose tissue in human obesity. Am J Physiol Endocrinol Metab 293:E656–E665CrossRefPubMed Maury E, Ehala-Aleksejev K, Guiot Y, Detry R, Vandenhooft A, Brichard SM (2007) Adipokines oversecreted by omental adipose tissue in human obesity. Am J Physiol Endocrinol Metab 293:E656–E665CrossRefPubMed
25.
go back to reference Schluns KS, Lefrancois L (2003) Cytokine control of memory T cell development and survival. Nat Rev Immunol 3:269–279CrossRefPubMed Schluns KS, Lefrancois L (2003) Cytokine control of memory T cell development and survival. Nat Rev Immunol 3:269–279CrossRefPubMed
26.
go back to reference Cosenza L, Gorgun G, Urbano A, Foss F (2002) Interleukin-7 receptor expression and activation in nonhaematopoietic neoplastic cell lines. Cell Signal 14:317–325CrossRefPubMed Cosenza L, Gorgun G, Urbano A, Foss F (2002) Interleukin-7 receptor expression and activation in nonhaematopoietic neoplastic cell lines. Cell Signal 14:317–325CrossRefPubMed
27.
go back to reference Zoth N, Weigt C, Laudenbach-Leschowski U, Diel P (2010) Physical activity and estrogen treatment reduce visceral body fat and serum levels of leptin in an additive manner in a diet induced animal model of obesity. J Steroid Biochem Mol Biol 122:100–105CrossRefPubMed Zoth N, Weigt C, Laudenbach-Leschowski U, Diel P (2010) Physical activity and estrogen treatment reduce visceral body fat and serum levels of leptin in an additive manner in a diet induced animal model of obesity. J Steroid Biochem Mol Biol 122:100–105CrossRefPubMed
28.
go back to reference Riant E, Waget A, Cogo H, Arnal JF, Burcelin R, Gourdy P (2009) Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology 150:2109–2117CrossRefPubMed Riant E, Waget A, Cogo H, Arnal JF, Burcelin R, Gourdy P (2009) Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology 150:2109–2117CrossRefPubMed
29.
go back to reference Fleming HE, Paige CJ (2001) Pre-B cell receptor signaling mediates selective response to IL-7 at the pro-B to pre-B cell transition via an ERK/MAP kinase-dependent pathway. Immunity 15:521–531CrossRefPubMed Fleming HE, Paige CJ (2001) Pre-B cell receptor signaling mediates selective response to IL-7 at the pro-B to pre-B cell transition via an ERK/MAP kinase-dependent pathway. Immunity 15:521–531CrossRefPubMed
30.
go back to reference Yasuda T, Sanjo H, Pages G et al (2008) Erk kinases link pre-B cell receptor signaling to transcriptional events required for early B cell expansion. Immunity 28:499–508CrossRefPubMed Yasuda T, Sanjo H, Pages G et al (2008) Erk kinases link pre-B cell receptor signaling to transcriptional events required for early B cell expansion. Immunity 28:499–508CrossRefPubMed
31.
go back to reference Prusty D, Park BH, Davis KE, Farmer SR (2002) Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARγ) and C/EBPα gene expression during the differentiation of 3T3-L1 preadipocytes. J Biol Chem 277:46226–46232CrossRefPubMed Prusty D, Park BH, Davis KE, Farmer SR (2002) Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARγ) and C/EBPα gene expression during the differentiation of 3T3-L1 preadipocytes. J Biol Chem 277:46226–46232CrossRefPubMed
32.
go back to reference Bost F, Aouadi M, Caron L et al (2005) The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes 54:402–411CrossRefPubMed Bost F, Aouadi M, Caron L et al (2005) The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes 54:402–411CrossRefPubMed
33.
go back to reference Morris AJ, Martin SS, Haruta T et al (1996) Evidence for an insulin receptor substrate 1 independent insulin signaling pathway that mediates insulin-responsive glucose transporter (GLUT4) translocation. Proc Natl Acad Sci U S A 93:8401–8406PubMedCentralCrossRefPubMed Morris AJ, Martin SS, Haruta T et al (1996) Evidence for an insulin receptor substrate 1 independent insulin signaling pathway that mediates insulin-responsive glucose transporter (GLUT4) translocation. Proc Natl Acad Sci U S A 93:8401–8406PubMedCentralCrossRefPubMed
34.
go back to reference Ueki K, Kondo T, Kahn CR (2004) Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol Cell Biol 24:5434–5446PubMedCentralCrossRefPubMed Ueki K, Kondo T, Kahn CR (2004) Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol Cell Biol 24:5434–5446PubMedCentralCrossRefPubMed
35.
go back to reference Cornish AL, Chong MM, Davey GM et al (2003) Suppressor of cytokine signaling-1 regulates signaling in response to interleukin-2 and other gamma c-dependent cytokines in peripheral T cells. J Biol Chem 278:22755–22761CrossRefPubMed Cornish AL, Chong MM, Davey GM et al (2003) Suppressor of cytokine signaling-1 regulates signaling in response to interleukin-2 and other gamma c-dependent cytokines in peripheral T cells. J Biol Chem 278:22755–22761CrossRefPubMed
36.
go back to reference Leguisamo NM, Lehnen AM, Machado UF et al (2012) GLUT4 content decreases along with insulin resistance and high levels of inflammatory markers in rats with metabolic syndrome. Cardiovasc Diabetol 11:100PubMedCentralCrossRefPubMed Leguisamo NM, Lehnen AM, Machado UF et al (2012) GLUT4 content decreases along with insulin resistance and high levels of inflammatory markers in rats with metabolic syndrome. Cardiovasc Diabetol 11:100PubMedCentralCrossRefPubMed
37.
go back to reference Gregor MF, Hotamisligil GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29:415–445CrossRefPubMed Gregor MF, Hotamisligil GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29:415–445CrossRefPubMed
38.
go back to reference Chung S, Lapoint K, Martinez K, Kennedy A, Boysen Sandberg M, McIntosh MK (2006) Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology 147:5340–5351CrossRefPubMed Chung S, Lapoint K, Martinez K, Kennedy A, Boysen Sandberg M, McIntosh MK (2006) Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology 147:5340–5351CrossRefPubMed
39.
go back to reference Cinti S, Mitchell G, Barbatelli G et al (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46:2347–2355CrossRefPubMed Cinti S, Mitchell G, Barbatelli G et al (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46:2347–2355CrossRefPubMed
40.
Metadata
Title
IL-7 receptor deletion ameliorates diet-induced obesity and insulin resistance in mice
Authors
Miyoung Lee
Su Jin Song
Myung-Sook Choi
Rina Yu
Taesun Park
Publication date
01-10-2015
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 10/2015
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-015-3684-7

Other articles of this Issue 10/2015

Diabetologia 10/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.